Avanir to Provide More Human-Factor Data for Migraine Treatment

Avanir Pharmaceuticals, which previously said the FDA had questions about “human factor” study data for a migraine treatment, said it will provide new data.



from WSJ.com: US Business http://ift.tt/1zwxJRr

via IFTTT